| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:518565773:1994 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:518565773:1994?format=raw |
LEADER: 01994cam a2200445 a 4500
001 3961201
005 20221027010621.0
008 911113t19911991maua b 001 0 eng c
010 $a 91026122
020 $a0817635661 (hard : alk. paper)
020 $a3764335661 (hard : alk. paper)
035 $a(OCoLC)24175040
035 $a(OCoLC)ocm24175040
035 $a(CStRLIN)NYCM91-B6316
035 $9AFU6054HS
035 $a(NNC)3961201
035 $a3961201
040 $aDNLM/DLC$cDLC$dNNC-M
050 00 $aRC523$b.C49 1991
082 00 $a616.8/31061$220
245 00 $aCholinergic basis for Alzheimer therapy /$cedited by Robert Becker, Ezio Giacobini.
260 $aBoston :$bBirkhäuser,$c[1991], ©1991.
300 $ax, 494 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAdvances in Alzheimer therapy
504 $aIncludes bibliographical references and index.
650 0 $aAlzheimer's disease$xChemotherapy.
650 0 $aCholinergic mechanisms.$0http://id.loc.gov/authorities/subjects/sh86004795
650 0 $aCholinesterase inhibitors$xTherapeutic use.
650 0 $aNerve growth factor$xTherapeutic use.
650 2 $aAlzheimer Disease$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D000544Q000188
650 2 $aCholinesterase Inhibitors$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D002800Q000627
650 2 $aNeurotransmitter Agents$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D018377Q000627
650 2 $aParasympathomimetics$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D010277Q000627
650 2 $aReceptors, Cholinergic$xdrug effects.$0https://id.nlm.nih.gov/mesh/D011950Q000187
700 1 $aBecker, Robert E.$0http://id.loc.gov/authorities/names/n86014250
700 1 $aGiacobini, Ezio.$0http://id.loc.gov/authorities/names/n80072341
830 0 $aAdvances in Alzheimer disease therapy.$0http://id.loc.gov/authorities/names/n88525959
852 00 $boff,hsl$hRC523$i.C49 1991